GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (FRA:6OP) » Definitions » Total Long-Term Assets

OSE Immunotherapeutics (FRA:6OP) Total Long-Term Assets : €54.03 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. OSE Immunotherapeutics's Total Long-Term Assets for the quarter that ended in Dec. 2024 was €54.03 Mil.

OSE Immunotherapeutics Total Long-Term Assets Historical Data

The historical data trend for OSE Immunotherapeutics's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics Total Long-Term Assets Chart

OSE Immunotherapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.14 57.67 54.58 51.58 54.03

OSE Immunotherapeutics Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.58 52.68 51.58 55.14 54.03

OSE Immunotherapeutics Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

OSE Immunotherapeutics Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

OSE Immunotherapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (FRA:6OP) » Definitions » Total Long-Term Assets
Comparable Companies
XPAR:NANO XPAR:IPH XPAR:MAAT XPAR:GNFT XPAR:TNG XPAR:ALCLS XPAR:ADOC XPAR:ALSEN XPAR:DBV XPAR:ABNX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
0RAD:UK OSE:France 6OP:Germany
Address
22, Boulevard Benoni Goullin, Nantes, FRA, 44200
Website
http://www.ose-immuno.com
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics Headlines

No Headlines